424
Views
59
CrossRef citations to date
0
Altmetric
Research Article

Women's views of antidepressants in the treatment of postnatal depression

, &
Pages 221-233 | Published online: 07 Jul 2009

References

  • World Health Organisation. International Classification of Diseases, 10th edn. Geneva, 1992.
  • O’Hara MW, Swain AM. Rates and risk of postpartum depression - a meta analysis. International Review of Psychiatry 1996; 8:37–54
  • Kumar R. An overview of postpartum psychiatric mood disorders. Clinical Issues in Perinatal Women’s Health Nursing 1990; 1: 351–358
  • Bebbington PE. The Epidemiology of Depressive Illness. In Montgomery S, ed. The Pharmacology of Depression, Oxford: Oxford University Press, 1992.
  • Katon W, Roy-Byrne PP. Antidepressants in the medically ill: diagnosis and treatment in primary care. Clinical Chemistry 1988; 34(5):829–823
  • Cole SA, Sullivan M, Kathol R, et al. A model curriculum for mental disorders and behavioural problems in primary care. General Hospital Psychiatry 1995; 17:13–18
  • Freeling P, Rao BM, Paykel ES, et al. Unrecognised depression in general practice. BMJ 1985; 290:1880–1883
  • Cox JL, Holden JM, Sagovsky R, Detection of postnatal depression: development of the Edinburgh Postnatal Depression Scale. British Journal of Psychiatry 1987; 150:782–786
  • Whitton A, Warner R, Appleby L. The pathway to care in postnatal depression: women’s attitudes to postnatal depression and its treatment. British Journal of General Practice 1996; 46:427–428
  • Johnson FN. Different treatment modalities for recurrent bipolar affective disorders: an integrative approach. Psychotherapeutic Psychosomatics. 1986; 46 (1-2): 13–22
  • McCombs JS, Nichol MB, Stimmel GL, et al. The cost of antidepressant drug therapy failure: a study of antidepressant use patterns in a Medicaid population. Journal of Clinical Psychiatry. 1990; 51(Suppl):60–69
  • Thompson C. Management of depression in real-life settings: knowledge gained from largescale clinical trials. International Clinical Psychopharmacology. 1994; 9(3):21–25
  • Lepine JP, Gastpar M, Mendlewicz J et al. Depression in the community: the first pan- European study DEPRES (Depression Research in European Society). International Clinical Psychopharmacology 1997; 12(1):19–29
  • Paykel ES, Priest RG. Recognition and management of depression in general practice: consensus statement. BMJ, 1992; 305: 1198–1202
  • Scott AIF, Freeman CPL. Edinburgh primary care depression study: treatment outcome, patient satisfaction and costs after 16 weeks. BMJ, 1992; 304:883–887
  • Appleby L, Warner R, Whitton A et al. A controlled study of fluoxetine and cognitivebehavioural counselling in the treatment of postnatal depression. BMJ 1997; 314:932–936
  • Hoffbrand S, Howard L, Crawley H. Antidepressant drug treatment for postnatal depression (Protocol for a Cochrane Review). In: The Cochrane Library, Issue 3, Oxford: Update Software, 2000.
  • Boath E, Henshaw C. The treatment of postnatal depression: a comprehensive literature review. Journal of Reproductive and Infant Psychology 2001;19(3):215 - 248
  • Roy A, Cole K, Goldman Z et al. Fluoxetine treatment of postpartum depression. American Journal of Psychiatry 1993;150(8):1273
  • Stowe ZN, Casarella J, Landry J et al. Sertraline in the treatment of women with postpartum major depression. Depression 1995; 3:49–55
  • Cerruti R, Sichel MP, Perin P et al. Psychological distress during puerperium: a novel therapeutic approach using Sadenosylmethionine. Current Therapeutic Research 1993; 53(6):707–717
  • Fava GA, Kellner R, Perini GI et al. Italian validation of the Symptom Rating Test (SRT) and Symptom Questionnaire (SQ). Canadian Journal of Psychiatry, 1986; 28:117–123
  • Hamilton M. Hamilton depression scale. In W. Guy. Rockville, MD (ed) ECDEU Assessment Manual of Psychopharmacology: National Institute of Mental Health 1976.
  • SIGN 60. Postnatal Depression - A national clinical guideline. Edinburgh: Scottish Intercollegiate Guidelines Network, June 2002.
  • Prescription Trends Survey. American Druggist 1993; 208(1):31–34
  • Austin MPV, Mitchell PB. Use of psychotropic medications in breast feeding women: acute and prophylactic treatment. Australian and New Zealand Journal of Psychiatry, 1998; 32:778–784
  • Misri S, Burgmann A, Kostaras D. Are SSRIs safe for pregnant and breastfeeding women? Canadian Family Physician 2000; 46:626–633
  • Yoshida K, Smith B, Craggs M et al. Neuroleptic drugs in breast milk: a study of pharmacokinetics and of possible adverse effects in breast-fed infants. Psychological Medicine 1998; 28(1):81–91
  • Wisner KL, Perel JM, Findling KL. Antidepressant treatment during breastfeeding. American Journal of Psychiatry 1996; 153(9):1132–1137
  • Warner R, Appleby L, Whitton A, et al. Demographic and obstetric risk factors for postnatal psychiatric morbidity. British Journal of Psychiatry 1996; 168(5):607–611
  • Tyrer P. Prescribing psychotropic drugs in general practice. BMJ 1988; 27(296):588–589
  • Hendrick V, Altshuler L, Strouse T, et al. Postpartum and nonpostpartum depression: differences in presentation and response to pharmacological treatment. Depression and Anxiety 2000; 11(2):66–72
  • Field T, Morrow C, Valdern C, et al. Massage reduces anxiety in child and adolescent psychiatric patients. J. Acad. Child. Adolesc. Psychiatry 1992; 31(1):125–131
  • Murray L, Sinclair DL, Cooper P, et al. The socioemotional development of 5-year old children of postnatally depressed mothers. J. Child. Psychol. Psychiatry 1999; 40(8):1259–1271
  • Wrate RM, Rooney AC, Thomas PF et al. Postnatal depression and child development. A three-year follow-up study. British Journal of Psychiatry 1985; 146:622–627
  • Cogill SA, Caplan HL, Alexandra H, et al. Impact of maternal depression on the cognitive development of young children. BMJ 1986; 292:1165–1167
  • Caplan H, Cogill S, Alexandra H, et al. Maternal depression and the emotional development of the child. British Journal of Psychiatry 1989; 154:818–823
  • Ghodsian M, Zajicek E, Wolkind S. A longitudinal study of maternal depression and child behaviour problems. Journal of Child Psychology and Psychiatry 1984; 25:91–109
  • Stein A, Gath DH, Butcher J, et al. The relationship between post-natal depression and mother-child interaction. British Journal of Psychiatry 1991; 158:46–52
  • Murray L, Cooper PJ. The impact of postpartum depression on child development. International Review of Psychiatry 1996; 8:55–63
  • Murray L, Stanley C, Hooper F, et al. The role of infant factors in postnatal depression and mother-infant interactions. Developmental Medicine and Child Neurology 1996; 38:109–119
  • Sinclair D, Murray L. Effects of postnatal depression on childrens’ adjustment to school: Teacher’s reports. British Journal of Psychiatry 1998; 172:58–63
  • Coley RL, Chase-Lansdale PL. Adolescent pregnancy and parenthood: Recent evidence and future directions. American Psychologist 1998; 53(2):152–160
  • King M, Sibbald B, Ward E, et al. A randomised controlled-trial of non-directive counselling, cognitive behavioural therapy and usual general practitioner care in the management of depression as well as mixed anxiety and depression in primary care. Health Technology Assessment 2000; 4(19):1–83
  • Boath EH, Major K, Cox J. When the cradle falls II: the cost-effectiveness of treating postnatal depression in a psychiatric day hospital compared with routine primary care. Journal of Affective Disorders 2003; 74:159–166
  • Goldberg DP, Cooper B, Eastwood MR, et al. A standardized psychiatric interview for use in community surveys. British Journal of Preventive and Social Medicine 1970; 24(1):18–23
  • Spitzer RL, Endicot J, Robins E. Research diagnostic criteria: rationale and reliability. Archives of General Psychiatry 1978; 36:773–782
  • Boath EH, Cox J, Lewis M, et al. When the cradle falls: the treatment of postnatal depression in a psychiatric day hospital compared with routine primary care. Journal of Affective Disorders 1999; 55:13–151
  • Boath EH. (1999) The cost and effectiveness of two alternative approaches to the treatment of postnatal depression. Ph.D. Thesis, Keele University, Keele
  • Weber RP. Basic Content Analysis, 2nd edn. California: SAGE, 1990
  • Conrad P. The meaning of medications: another look at compliance. Social Science & Medicine 1985; 20(1):29–37
  • Wallenius SH, Vainio KK, Korhonen MJH, et al. Self-initiated modification of hypertension treatment in response to perceived problems. Ann Pharmacother 1995; 29:1213–1217
  • Boath E, Blenkinsopp A. The rise and rise of proton pump inhibitor drugs: a patients’ perspective. Social Science and Medicine 1997; 45(10):1571–1579
  • Morgan M, Watkins CJ. Managing hypertension: beliefs and responses to medication among cultural groups. Sociology Health and Illness 1988; 10(4):561–578
  • Mansbridge B, Fisher S. Public knowledge and attitudes about diazepam. Psychopharmacology 1984; 82:225–228
  • Paykel ES, Priest RG. Recognition and management of depression in general practice: consensus statement. BMJ 1992; 305:1198- 1202
  • Dunnell K, Cartwright A. Medicine Takers, Prescribers and Hoarders. London: Routledge, 1972
  • Arluke A. Judging drugs: patients’ conceptions of therapeutic efficacy in the treatment of arthritis. Hum Organ. 1980; 39(1):84–8
  • Priest RG, Vize C, Roberts A, et al. Lay people’s attitudes to treatment of depression: results of opinion poll for Defeat Depression Campaign just before its launch. BMJ 1996; 313(7061):858–9
  • Bertakis KD. The communication of information from physician to patient: a method for increasing the retention and satisfaction. Journal of Family Practice 1977; 5:217–222
  • Carr-Hill R. The measurement of patient satisfaction. Journal of Public Health Medicine 1992; 14(3):236–249
  • Guidelines in practice. Evidence-based guidelines for treating depressive disorders with antidepressants. Medendium Group Publishing Ltd, June 2000
  • Marinker M (ed.) From compliance to concordance: Achieving shared goals in medicine taking. Royal Pharmaceutical Society, 1997
  • Zajecka J, Fawcett J, Amsterdam J, et al. Safety of abrupt discontinuation of fluoxetine: a randomised, placebo controlled study. J Clin Psychopharmacol 1998; 18:193–197
  • Stahl MM, Lindquist M, Pettersson M, et al. Withdrawal reactions with selective serotonin reuptake inhibitors as reported to the WHO system. Eur J Clin Pharmacol 1997; 53:163–169
  • Tonks A. Withdrawal from paroxetine can be severe, warns FDA. BMJ 2002; 324:pp 260
  • Department of Health. The Expert Patient: A new approach to chronic disease management for the 21st century. London, 2000
  • Churchill R, Khaira M, Gretton V, et al. Treating depression in general practice: factors affecting patients’ treatment preferences. British Journal of General Practice 2000; 50(460):905–906
  • Holden JM, Sagovsky R, Cox J. Counselling in a general practice setting: a controlled study of health visitor intervention in treatment of postnatal depression. BMJ 1989; 298:223–226
  • Wickberg B, Hwang CP. Counselling of postnatal depression: A controlled study on a population based Swedish sample. Journal of Affective Disorders 1996; 39(3):209–216

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.